Decrease in Ovarian Platelet-Activating Factor during Ovulation in the Gonadotropin-Primed Immature Rat1
- 1 July 1989
- journal article
- research article
- Published by Oxford University Press (OUP) in Biology of Reproduction
- Vol. 41 (1) , 104-110
- https://doi.org/10.1095/biolreprod41.1.104
Abstract
Platelet-activating factor (PAF) is a biologically active phospholipid that is released locally during acute inflammatory reactions and tissue injury. Since there is evidence that the biochemical events of mammalian ovulation resemble an inflammatory reaction, the objective of this study was to determine whether ovarian levels of PAF change during ovulation. At 2-h intervals during the ovulatory process in gonadoptropin-primed 25-day-old Wistar rats, the ovaries were extirpated, homogenized, and extracted for lipids. The extracts were subjected to thin-layer chromatography (TLC), and the portion of the silica gel that comigrated with PAF was re-extracted and assayed for PAF activity. The PAF was measured (in fmole equivalents of synthetic PAF) by a bioassay based on the capacity of aliquots of the extracts to release [3H]-serotonin from platelets isolated from while bood of rabbits and prelabeled with [3H]-serotonin. The ovarian level of PAF decreased (p < 0.01) by 36% from 6.67 .+-. 0.77 to 4.27 .+-. 0.45 fmoles/mg ovary by 2 h after treatment with human chorionic gonadotropin (hCG), and it declined another 14% by 4 h after hCG. The ovarian PAF remained at this reduced level for up to 24 h after hCG. The administration of indomethacin (5 mg/rat, s.c.) or epostane (5 mg/rat, s.c.) at 1 h after hCG prevented ovulation, but neither drug affected the decline in ovarian PAF. Preliminary tests showed that the lipid extracts from the ovaries also contained PAF inhibitor(s) that comigrated with PAF on the TLC plates. Similar to PAF, the lipid-soluble inhibitor(s) decreased (p < 0.05) in the ovaries within 4 h after hCG treatment. In conclusion, ovarian PAF decreased at the beginning of the ovulatory process in rats, and the change in this vasoactive phospholipid provides further evidence that the biochemical events of mammalian ovulation resemble an inflammatory reaction.This publication has 19 references indexed in Scilit:
- INHALATION OF ENDOTOXIN STIMULATES ALVEOLAR MACROPHAGE PRODUCTION OF PLATELET-ACTIVATING-FACTORPublished by Elsevier ,1987
- Occurrence of an endogenous inhibitor of platelet-activating factor in rat liver.Journal of Biological Chemistry, 1986
- Ovarian increase in kinin-generating capacity in PMSG/hCG-primed immature ratAmerican Journal of Physiology-Endocrinology and Metabolism, 1986
- EVIDENCE THAT PLATELET-ACTIVATING-FACTOR MAY MEDIATE SOME ACUTE INFLAMMATORY RESPONSES - STUDIES WITH THE PLATELET-ACTIVATING-FACTOR ANTAGONIST, CV39881986
- Ionic and GTP regulation of binding of platelet-activating factor to receptors and platelet-activating factor-induced activation of GTPase in rabbit platelet membranes.Journal of Biological Chemistry, 1986
- Effects of serum albumin, indomethacin and histamine H1‐antagonists on Paf‐acether‐induced inflammatory responses in the skin of experimental animals and manBritish Journal of Pharmacology, 1985
- MORPHOLOGIC BASIS OF INCREASED VASCULAR-PERMEABILITY INDUCED BY ACETYL GLYCERYL ETHER PHOSPHORYLCHOLINE1984
- Survey of antiinflammatory agents and related drugs as inhibitors of ovulation in the rabbitFertility and Sterility, 1982
- Non-steroidal anti-inflammatory drugs if combined with anti-histamine and anti-serotonin agents interfere with the bronchial and platelet effects of “platelet-activating factor” (PAF-acether)European Journal of Pharmacology, 1982
- Physicochemical and Functional Identity of Rabbit Platelet-Activating Factor (PAF) Released in Vivo during IgE Anaphylaxis with PAF Released in Vitro from IgE Sensitized BasophilsThe Journal of Immunology, 1979